Hematologic Malignancy
Digestive System Lymphoma
CI-CAN-00000817Explore in graph →
Hematologic15 active trials
- NCIt
- C38162
Loading cancer entity…
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00000817Explore in graph →
Rankings
7 current ranking rows (latest year per scope). Each row lists the scope, the formula version, the value and the exact inputs that produced it.
| Metric | Scope | Rank / eligible | Δ | Value | Percentile | Confidence | Formula | Generated | Inputs |
|---|---|---|---|---|---|---|---|---|---|
| Publications, last 12 months | World · both sexes · all ages · latest · all malignant entities | #542 / 2,294 | = | 37 count | 76.4 | Medium confidence | ci-pubs-12m-v1 | Sep 30, 2026 | showformula: literature_counts.count WHERE window_key = 12m
inputs hash b1963bee32e72b8b6e51efec Trace lineage (admin) |
| Publications, last 5 years | World · both sexes · all ages · latest · all malignant entities | #631 / 2,873 | = | 139 count | 78.1 | Medium confidence | ci-pubs-5y-v1 | Sep 30, 2026 | showformula: literature_counts.count WHERE window_key = 5y (query stored per row)
inputs hash 7b01855837dd178dff17a0c3 Trace lineage (admin) |
| Publication growth | World · both sexes · all ages · latest · all malignant entities | #18 / 286 | = | 1.68 ratio | 94 | Medium confidence | ci-pub-growth-v1 | Sep 30, 2026 | showformula: publications_12m / (publications_5y_prior / 5)
inputs hash f24de54682c3ca3c4a7306df Trace lineage (admin) |
| Active clinical trials | World · both sexes · all ages · latest · all malignant entities | #502 / 1,654 | = | 15 count | 69.7 | Medium confidence | ci-active-trials-v1 | Sep 30, 2026 | showformula: COUNT(DISTINCT trial) FROM trial_conditions JOIN clinical_trials WHERE cancer_id IN descendants(cancer) AND study_type = INTERVENTIONAL AND overall_status IN (RECRUITING, NOT_YET_RECRUITING, ENROLLING_BY_INVITATION, ACTIVE_NOT_RECRUITING)
inputs hash d8f333d5bfdbadb41c05f9e2 Trace lineage (admin) |
| Recruiting clinical trials | World · both sexes · all ages · latest · all malignant entities | #547 / 1,284 | = | 6 count | 57.4 | Medium confidence | ci-recruiting-trials-v1 | Sep 30, 2026 | showformula: COUNT(DISTINCT trial) … overall_status = RECRUITING AND study_type = INTERVENTIONAL
inputs hash 00002505dcded3e0217a182d Trace lineage (admin) |
| Sponsor concentration (HHI) | World · both sexes · all ages · latest · all malignant entities | #96 / 614 | = | 0.156 index (0–1) | 84.5 | Medium confidence | ci-sponsor-hhi-v1 | Sep 30, 2026 | showformula: Σ (active_trials_by_lead_sponsor / active_trials)² over the cancer and its descendants
|
| Trial termination share | World · both sexes · all ages · latest · all malignant entities | #261 / 454 | = | 0.33 ratio | 42.6 | Medium confidence | ci-trial-termination-v1 | Sep 30, 2026 | showformula: (terminated + withdrawn) / (completed + terminated + withdrawn) WHERE first_posted_date ≥ 2010-01-01 AND study_type = INTERVENTIONAL
|
Computed Ranks are competition ranks (ties share a rank). Percentile = share of eligible entities ranked at or below this one in the ranking direction.
"Deadliest" is ambiguous: annual deaths, age-standardized mortality rate, mortality-to-incidence ratio and 5-year survival rank cancers differently. CancerIndex publishes each as a separate metric.
inputs hash 909c6c96975dbbd1461c83c4
inputs hash aebac3d92951539ea771c6d9
Unmet need · computed
No research-gap components for this entity